bromocriptine has been researched along with Dystonia in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (68.18) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lees, AJ; Stern, GM | 1 |
| Hallett, M | 1 |
| Berger, PA; Stahl, SM | 2 |
| Angelini, L; Broggi, G; Caraceni, T; Giovannini, P; Girotti, F; Nardocci, N; Scigliano, G | 1 |
| Destee, A | 1 |
| Luquin, MR; Obeso, JA | 1 |
| Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR | 1 |
| Leiguarda, R; Merello, M; Sabe, L; Starkstein, S | 1 |
| Cornelius, L; Factor, SA; Ingenito, A; Sanchez-Ramos, JR; Sheldon, C; Singer, C; Weiner, WJ | 1 |
| Duchek, M; Ekberg, R; Fehling, C; Johansson, F; Johnels, B; Lindvall, B; Nordin, G; Olsson, JE; Sidén, A; Steg, G | 1 |
| Brown, D; Factor, SA; Molho, ES; Podskalny, GD | 1 |
| Finken, MJ; Ramaker, C; Van de Beek, WJ; van Hilten, JJ | 1 |
| Iivanainen, M; Juntunen, J; Kaste, M; Kruus, S; Ranta, T; Seppälä, M | 1 |
| Brunk, U; Eeg-Olofsson, O; Lindvall, B; Olsson, JE | 1 |
| Goldman, M; Luchins, DJ | 1 |
| Patterson, JF | 1 |
| Aso, K; Furune, S; Negoro, T; Nomura, K; Takahashi, I; Watanabe, K; Yamamoto, N | 1 |
| Klawans, HL; Paleologos, N | 1 |
| Bruno, G; Calne, DB; Chase, TN; Foster, NL; LeWitt, PA; Newman, RP; Shults, C | 1 |
| Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Grau-Veciana, JM; Peiró Grasa, A | 1 |
2 review(s) available for bromocriptine and Dystonia
| Article | Year |
|---|---|
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis | 1984 |
Bromocriptine for levodopa-induced motor complications in Parkinson's disease.
Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease | 2000 |
6 trial(s) available for bromocriptine and Dystonia
| Article | Year |
|---|---|
Bromocriptine in dystonia.
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Double-Blind Method; Dystonia; Female; Humans; Male; Middle Aged | 1981 |
Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias.
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Dystonia; Female; Haloperidol; Humans; Male; Middle Aged; Neurotransmitter Agents; Physostigmine; Receptors, Cholinergic; Receptors, Dopamine; Torticollis | 1982 |
[Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
Topics: Adult; Bromocriptine; Child; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Dystonia; Dystonia Musculorum Deformans; Female; Humans; Huntington Disease; Male; Movement Disorders; Nervous System Diseases; Parkinson Disease; Shy-Drager Syndrome; Syndrome; Torticollis | 1984 |
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
Topics: Activities of Daily Living; Aged; Bromocriptine; Chorea; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease | 1993 |
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
Topics: Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Motor Activity; Parkinson Disease; Time Factors | 1993 |
Dystonia: treatment with bromocriptine.
Topics: Adult; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Dystonia; Female; Humans; Male; Middle Aged; Random Allocation | 1985 |
15 other study(ies) available for bromocriptine and Dystonia
| Article | Year |
|---|---|
Bromocriptine in treatment of levodopa-induced end-of-dose dystonia.
Topics: Bromocriptine; Dystonia; Female; Humans; Levodopa; Middle Aged; Parkinson Disease | 1980 |
Bromocriptine for levodopa-induced end-of-dose dystonia.
Topics: Aged; Bromocriptine; Dystonia; Female; Humans; Levodopa; Parkinson Disease | 1981 |
Idiopathic dystonia: neuropharmacological study.
Topics: Adolescent; Adult; Aged; Bromocriptine; Dystonia; Female; Humans; Male; Middle Aged; Pimozide; Syndrome; Torticollis; Trihexyphenidyl | 1982 |
Bromocriptine and lisuride in dystonias.
Topics: Bromocriptine; Dystonia; Ergolines; Humans; Lisuride | 1984 |
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease | 1994 |
Bromocriptine-induced dystonia in patients with aphasia and hemiparesis.
Topics: Adult; Aged; Aphasia; Brain; Bromocriptine; Dystonia; Female; Hemiplegia; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 1993 |
The effect of dancing on dystonia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dancing; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders; Trihexyphenidyl; Vitamin E | 1996 |
Effect of bromocriptine on dystonic-athetoid dyskinesias in mentally retarded patients.
Topics: Administration, Oral; Adolescent; Adult; Athetosis; Bromocriptine; Double-Blind Method; Drug Evaluation; Dystonia; Female; Humans; Intellectual Disability; Male; Middle Aged; Movement Disorders; Prolactin | 1978 |
Dopa-responsive dystonia with depigmentation of the substantia nigra and formation of Lewy bodies.
Topics: Adult; Bromocriptine; Cerebrospinal Fluid Proteins; Dihydroxyphenylalanine; Dopamine; Drug Therapy, Combination; Dystonia; Female; Humans; Lewy Bodies; Neuropeptides; Pigmentation; Substantia Nigra | 1992 |
High-dose bromocriptine in a case of tardive dystonia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Dystonia; Humans; Male | 1985 |
Bromocriptine sensitization of neuroleptic-induced acute dystonia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Bromocriptine; Dystonia; Female; Humans; Receptors, Dopamine | 1988 |
[Bromocriptine and L-dopa therapy: comparison in a case of hereditary progressive dystonia with marked diurnal fluctuations].
Topics: Adolescent; Bromocriptine; Dystonia; Female; Humans; Levodopa | 1987 |
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis | 1986 |
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors | 1985 |
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].
Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease | 1985 |